The USA, Japan and Britain are leading the race in stem cell therapy with regards to finding a cure for blindness and preventing loss of eye sight, a very prevalent issue for aging populations.
Dr. Pete Coffey, of the UCL School of Ophthalmology has led The London Project to Cure Blindness.
Advanced age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment in the world. As many as 11 million people in the United States have some form of age-related macular degeneration.
By the year 2020 there will be 450,000 Californians struck with AMD unless modern technology intervenes.
Japan and Britain also face a future with large numbers of aging humans who may lose their eyesight from AMD.
For good reason, these countries are investing millions into stem cell incentives to ensure modern day technologies and medical advancements can preserve the independence of their aging populations for as long as possible. Preserving one’s eye sight is one of the most valuable aspects of independence.
Watch this short video below where Dr. Pete Coffey talks about this work being one of his finest accomplishments to date.
